FOXO Technologies Inc. – Filings and Transcripts

OTC: FOXOD
Share price (7/17/26): $0.06
Market cap (7/17/26): $268 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 03/31/26 Q1

ended 12/31/25 FY 2025

Late annual filing notification for FY 2025

ended 09/30/25 Q3

ended 06/30/25 Q2

Prospectuses and Registrations Filter

Prospectus supplement

Initial registration of new securities

Exempt offering of securities – amended

Exempt offering of securities

Draft registration statement

Ownership Filter

Sabby Management, LLC

Dowling Vincent J. Jr

Rennova Health Inc

News Filter

Subsidiary Vector Biosource, Inc. Enters Into Definitive Agreement to Acquire Four Blood Collection Centers From Grifols Bio Supplies, Inc

Material Definitive Agreement, Financial Statements or Exhibits

CEO Seamus Lagan Provides Mid-Year Update to Shareholders

Announces Completion of Reverse Stock Split

Inc., Forms Strategic Partnership With Longevityfp Technologies, LLC. to Commercialize FOXO’s Epigenetics Technology

Proxies Filter

Preliminary info

Preliminary info

Other Filter

Notice of effectiveness

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness